90 related articles for article (PubMed ID: 27157353)
1. The Role of Community Engagement in Novel HIV Research in Infants.
Shah SK; Wilfond BS
Perspect Biol Med; 2016; 58(3):344-7. PubMed ID: 27157353
[TBL] [Abstract][Full Text] [Related]
2. HIV Remission in Neonates: Ethical and Human Rights Considerations.
Shah SK; Wilfond BS
Perspect Biol Med; 2016; 58(3):341-3. PubMed ID: 27157352
[No Abstract] [Full Text] [Related]
3. Inducing HIV Remission in Neonates: Child Rights and Research Ethics.
Wade K; Antommaria AH
Perspect Biol Med; 2016; 58(3):348-54. PubMed ID: 27157354
[TBL] [Abstract][Full Text] [Related]
4. Equitable treatment for HIV/AIDS clinical trial participants: a focus group study of patients, clinician researchers, and administrators in Western Kenya.
Shaffer DN; Yebei VN; Ballidawa JB; Sidle JE; Greene JY; Meslin EM; Kimaiyo SJ; Tierney WM
J Med Ethics; 2006 Jan; 32(1):55-60. PubMed ID: 16373525
[TBL] [Abstract][Full Text] [Related]
5. Broadening community engagement in clinical research: Designing and assessing a pilot crowdsourcing project to obtain community feedback on an HIV clinical trial.
Day S; Mathews A; Blumberg M; Vu T; Rennie S; Tucker JD
Clin Trials; 2020 Jun; 17(3):306-313. PubMed ID: 32009466
[TBL] [Abstract][Full Text] [Related]
6. Post-trial access to antiretrovirals: who owes what to whom?
Millum J
Bioethics; 2011 Mar; 25(3):145-54. PubMed ID: 19594728
[TBL] [Abstract][Full Text] [Related]
7. Clinical Trial Design for HIV Prevention Research: Determining Standards of Prevention.
Dawson L; Zwerski S
Bioethics; 2015 Jun; 29(5):316-23. PubMed ID: 25230397
[TBL] [Abstract][Full Text] [Related]
8. Involving communities in the design of clinical trial protocols: the BAN Study in Lilongwe, Malawi.
Corneli AL; Piwoz EG; Bentley ME; Moses A; Nkhoma JR; Tohill BC; Adair L; Mtimuni B; Ahmed Y; Duerr A; Kazembe P; van der Horst C;
Contemp Clin Trials; 2007 Jan; 28(1):59-67. PubMed ID: 17000137
[TBL] [Abstract][Full Text] [Related]
9. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
10. Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa.
Mamotte N; Wassenaar D; Koen J; Essack Z
BMC Med Ethics; 2010 Mar; 11():3. PubMed ID: 20211030
[TBL] [Abstract][Full Text] [Related]
11. Assessing the impact of a modified informed consent process in a South African HIV/AIDS research trial.
Penn C; Evans M
Patient Educ Couns; 2010 Aug; 80(2):191-9. PubMed ID: 19963332
[TBL] [Abstract][Full Text] [Related]
12. 'It looks like you just want them when things get rough': civil society perspectives on negative trial results and stakeholder engagement in HIV prevention trials.
Koen J; Essack Z; Slack C; Lindegger G; Newman PA
Dev World Bioeth; 2013 Dec; 13(3):138-48. PubMed ID: 22998395
[TBL] [Abstract][Full Text] [Related]
13. An update and review of antiretroviral therapy.
Piacenti FJ
Pharmacotherapy; 2006 Aug; 26(8):1111-33. PubMed ID: 16863488
[TBL] [Abstract][Full Text] [Related]
14. HIV trial attacked.
Check Hayden E
Nature; 2014 Jun; 510(7505):324. PubMed ID: 24943939
[No Abstract] [Full Text] [Related]
15. Reported consent processes and demographics: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
Denning E; Sharma S; Smolskis M; Touloumi G; Walker S; Babiker A; Clewett M; Emanuel E; Florence E; Papadopoulos A; Sánchez A; Tavel J; Grady C;
HIV Med; 2015 Apr; 16 Suppl 1(0 1):24-9. PubMed ID: 25711320
[TBL] [Abstract][Full Text] [Related]
16. Darunavir: after multiple antiretroviral treatment failure: another option.
Prescrire Int; 2008 Jun; 17(95):109. PubMed ID: 18629967
[TBL] [Abstract][Full Text] [Related]
17. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG;
Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299
[TBL] [Abstract][Full Text] [Related]
18. Mind the gap: An empirical study of post-trial access in HIV biomedical prevention trials.
Haire B; Jordens C
Dev World Bioeth; 2015 Aug; 15(2):85-97. PubMed ID: 26193849
[TBL] [Abstract][Full Text] [Related]
19. Reciprocity and post-trial access for participants in antiretroviral therapy trials.
Merritt M; Grady C
AIDS; 2006 Sep; 20(14):1791-4. PubMed ID: 16954719
[No Abstract] [Full Text] [Related]
20. Cultural feasibility studies in preparation for clinical trials to reduce maternal-infant HIV transmission in Haiti.
Coreil J; Losikoff P; Pincu R; Mayard G; Ruff AJ; Hausler HP; Desormeau J; Davis H; Boulos R; Halsey NA
AIDS Educ Prev; 1998 Feb; 10(1):46-62. PubMed ID: 9505098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
